Sorry, we couldn't find any posts. Please try a different search.
Breaking News
Can we change the Biopharma Supply Chain Game so that Everyone Gets a Trophy?
by Lynn Stephenson, PhD
Welcome to Emerging BioTalk!
Here, innovators like you will have access to technical and thought leadership content from experts you can trust to help you accelerate your path to commercialization.
As a member of this community, we invite you to share your voice and contribute a blog post of your own by visiting our Submit A Blog Post page.
Finally, to be informed of the latest news and announcements, we invite you to subscribe by clicking “subscribe to our blog” just below.
Thank you for visiting our blog, and we hope to see you again soon!
Welcome to Emerging BioTalk!
Here, innovators like you will have access to technical and thought leadership content from experts you can trust to help you accelerate your path to commercialization.
As a member of this community, we invite you to share your voice and contribute a blog post of your own by visiting our Submit A Blog Post page.
Finally, to be informed of the latest news and announcements, we invite you to subscribe by clicking “subscribe to our blog” just below.
Thank you for visiting our blog, and we hope to see you again soon!
Bridging the Sponsor – CMO Data Gulf
Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…
by Jessica Hogan
Watch Now: Emerging Biotech On-Demand Event
Click HERE to watch the On-Demand Event Abstracts The Current State of Emerging Biotech Venture Capital & How…
by Jessica Hogan
Good Laboratory Practice and the Impact on Start Up Companies
The definition of Good Laboratory Practice (GLP) is given by the Organization for Economic Co-operation and Development (OECD)…
by Jason Cyr and Lynn Neild
Curious to learn more on PAT, Raman Spectroscopy, and Chemometrics?
Are you curious about Process Analytical Technologies (PAT), Raman spectroscopy, chemometrics and Raman applications in bioprocessing? Watch this 4 part interview series: PAT and Raman Meet the Experts Interview Series.
by Carole Inglevert
What to consider for a modular facility with closed processing
The biopharmaceutical industry trends towards new product classes and smaller batch sizes drives even a greater need for…
by Sarah Le Merdy, Alejandro Kaiser, PE, Jérome Dalin and JP Bornholdt, AIA, PE, LEED AP
Watch Now: Cell & Gene Therapy On-Demand Event
Click HERE to watch the On Demand Event Abstracts Riding the Gene Therapy Roller Coaster Ratish Krishnan, Senior Strategy…
by Jessica Hogan
mAbs
Bridging the Sponsor – CMO Data Gulf
Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…
by Jessica Hogan
Watch Now: mAbs and ADCs On Demand Event
Click HERE to watch the On Demand Event. Abstracts Building a Successful mAb Platform using the CHOZN® Cell…
by Jessica Hogan
Roundtable Discussion – Which International Markets Can we Anticipate Significant Developments?
Great insights shared by market leaders at Pharma’s Almanac roundtable discussion. Click HERE to access the full summary.
by Jessica Hogan
Vaccines are entering a new era and recently we hosted a virtual event to share insights on market trends, challenges, and potential solutions regarding the future of vaccine manufacturing.
In this On-Demand version of the presentations, key opinion leaders from MilliporeSigma, Hileman Laboratories Singapore, Baylor College of Medicine or Biofarma, provide a fascinating story of the behind of the scenes development of the recent pandemic and how long-term collaboration to optimize a neglected tropical disease vaccine platform transformed into the COVID-19 vaccine candidates.
by Carole Inglevert
mRNA Process and Cost Modeling: A Tool to Optimize Process Development
mRNA technology has proven to enable rapid drug development. mRNA is an attractive modality to work with because of its relative simplicity compared to other biologics; it is wholly synthetic and does not require cellular materials.
by Carole Inglevert
Key Benefits of PCR-based mRNA manufacturing for clinical development
mRNA technology offers many opportunities but the development and manufacturing of mRNA-based vaccines and therapeutics present a number of challenges. Learn more about the opportunities of the mRNA technology and how to overcome drug development and manufacturing challenges to bring your mRNA-based therapies to market in this first webinar.
by Dr. Julian Mochayedi and Eike Joest
Supply Spotlight
Can we change the Biopharma Supply Chain Game so that Everyone Gets a Trophy?
There is a popular board game based on a global disease outbreak that is generally rated 5 stars. As for the real Covid-19 pandemic, it would be hard to find a single person in the Biopharma industry who would give the supply chain performance during the pandemic that kind of high review.
by Lynn Stephenson, PhD
Video Interview: How to achieve a more robust supply chain
Watch Now Will your supply chain hold up to extreme weather? Pandemics? Civil unrest? Catastrophic events have led…
by Jessica Hogan
Vaccines
Vaccines are entering a new era and recently we hosted a virtual event to share insights on market trends, challenges, and potential solutions regarding the future of vaccine manufacturing.
In this On-Demand version of the presentations, key opinion leaders from MilliporeSigma, Hileman Laboratories Singapore, Baylor College of Medicine or Biofarma, provide a fascinating story of the behind of the scenes development of the recent pandemic and how long-term collaboration to optimize a neglected tropical disease vaccine platform transformed into the COVID-19 vaccine candidates.
by Carole Inglevert
Can we change the Biopharma Supply Chain Game so that Everyone Gets a Trophy?
There is a popular board game based on a global disease outbreak that is generally rated 5 stars. As for the real Covid-19 pandemic, it would be hard to find a single person in the Biopharma industry who would give the supply chain performance during the pandemic that kind of high review.
by Lynn Stephenson, PhD
mRNA Process and Cost Modeling: A Tool to Optimize Process Development
mRNA technology has proven to enable rapid drug development. mRNA is an attractive modality to work with because of its relative simplicity compared to other biologics; it is wholly synthetic and does not require cellular materials.
by Carole Inglevert
Vaccines are entering a new era and recently we hosted a virtual event to share insights on market trends, challenges, and potential solutions regarding the future of vaccine manufacturing.
In this On-Demand version of the presentations, key opinion leaders from MilliporeSigma, Hileman Laboratories Singapore, Baylor College of Medicine or Biofarma, provide a fascinating story of the behind of the scenes development of the recent pandemic and how long-term collaboration to optimize a neglected tropical disease vaccine platform transformed into the COVID-19 vaccine candidates.
by Carole Inglevert
Can we change the Biopharma Supply Chain Game so that Everyone Gets a Trophy?
There is a popular board game based on a global disease outbreak that is generally rated 5 stars. As for the real Covid-19 pandemic, it would be hard to find a single person in the Biopharma industry who would give the supply chain performance during the pandemic that kind of high review.
by Lynn Stephenson, PhD
mRNA Process and Cost Modeling: A Tool to Optimize Process Development
mRNA technology has proven to enable rapid drug development. mRNA is an attractive modality to work with because of its relative simplicity compared to other biologics; it is wholly synthetic and does not require cellular materials.
